THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.
about
The nature of the virus receptors of red cells; evidence on the chemical nature of the virus receptors of red cells and of the existence of a closely analogous substance in normal serumChimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 virusesThe osmotic stress response of split influenza vaccine particles in an acidic environment.Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.Influenza A virus isolation, culture and identification1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity.Flexible label-free quantitative assay for antibodies to influenza virus hemagglutininsCoated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.Genetic Characterization of Influenza A (H1N1) Pandemic 2009 Virus Isolates from Mumbai.Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles.Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Cellular scent of influenza virus infection.Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time.Influenza hemagglutinin and neuraminidase membrane glycoproteinsSerologic assays for influenza surveillance, diagnosis and vaccine evaluation.Increased hand washing reduces influenza virus surface contamination in Bangkok households, 2009-2010.Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analysesChallenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.Comparison of serological assays for detecting antibodies in ducks exposed to H5 subtype avian influenza virusEfficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments.Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.Antibody landscapes after influenza virus infection or vaccination.Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination.Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickensOptimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007.Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication)A study of acute respiratory disease in the community of Port Chalmers. II. Influenza A/Port Chalmers/1/73: intrafamilial spread and the effect of antibodies to the surface antigensUse of single radial immunodiffusion test for serological studies in volunteers inoculated with live attenuated influenza virusThe postnatal acquisition of factors which affect the influenza haemagglutination-inhibition test.ANTIGENIC RELATIONSHIP OF BRITISH SWINE INFLUENZA STRAINS TO STANDARD HUMAN AND SWINE INFLUENZA VIRUSES : THE USE OF CHICKEN AND FERRET ANTISERA IN RED CELL AGGLUTINATION.TRANSMISSION OF EPIDEMIC GASTROENTERITIS TO HUMAN VOLUNTEERS BY ORAL ADMINISTRATION OF FECAL FILTRATESThe pathogenesis of infection with a virulent (CG 179) and an avirulent (B) strain of Newcastle disease virus in the chicken. II. Development of antibody.Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. I. Biological properties and mechanism of actionMatrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary InfectionInactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses.
P2860
Q24681064-4AEF387C-235E-45B1-B091-17A7EB9FAC4BQ28365124-43C2E9A4-F9FC-4868-A866-11CC91162663Q30354213-AD4A0D72-9B4E-45CE-B812-FFDE6BF668A3Q30356476-2BDA293B-70B2-43C8-852C-C6C10B04A39CQ30367880-BB9F9060-CBEA-4179-8FE6-709332087FFAQ30386677-64BB4B36-1C17-4A80-B87E-F94AEDC562F1Q30391853-093F0CC8-8F54-4DCD-AEC9-83818A2E5D24Q30392895-642AD4C2-FB2B-469A-8E01-8629C2E8F7BBQ30398708-C038B0DA-17BE-418E-8B2F-8FC201231198Q30401898-F90FF025-3B15-4988-97CE-45693F4220A6Q30410686-986B9518-3D77-4464-8821-D1634590A3BAQ33683079-18B8C930-591A-450C-BA3E-AEB14D79ADF1Q33820732-69610F9D-0D2E-4833-BC2B-80C678FF5B2CQ33923347-E21EED5F-9D7C-4BF9-91C6-23250A55DC5DQ34029543-D2CF816F-62E8-4DB8-B9CD-CC5DE041C993Q34121109-A28BC1C4-E1C2-4391-B76A-CDA0FFBE5287Q34194336-AAE6FDC2-046D-4611-9131-7FAC651F0BDAQ34256923-44D9B8D4-9BB7-4074-911F-E0BDD7A30850Q34262280-4B0C5A4B-D76C-4556-B91E-FE1976E3ACE6Q34332806-ECBCFCBA-3E93-4022-94A0-15D062744D31Q34348163-110F5B21-B5FC-481E-A659-3935E143EB16Q34459383-B714DF90-952C-4F50-9899-0CF194238EF9Q34531413-5A4C25A8-193A-4B2B-BEC6-CDA573E26153Q34580640-235F5E81-AE48-454E-AF8F-37E6FD04052EQ34754812-1FACB878-B782-4D29-9135-14A0797A8530Q35191166-20BFAE95-59B7-4C03-9D3E-E571266765AFQ35235777-7E982C38-BBE5-4735-99A7-5C4006D0BAB1Q35531698-EA23AFA8-0C86-42CF-A05A-A4F14075D4FFQ35983371-0EAFB328-F967-441C-82BD-17795643F8B1Q36007528-6DA22AF8-7C11-437B-9851-6880780EC0EEQ36250689-A76FAEC1-13DB-4645-A7E1-C14CC79AC8F9Q36251711-05A07C53-9F3B-4381-BEB1-C7FAE784F760Q36258371-7E5DA8CE-3BDC-48D5-9C6A-CFA2503B0207Q36260261-F59CED35-2D10-4988-9997-BF1187AA1A19Q36260865-2105B557-2D8C-4828-BCD7-17F1974098DCQ36261627-2FE0B5AD-A46F-407C-872D-4FD32850B4E8Q36262316-D2B8B2BB-C419-4C7E-8B85-6D5C5896029DQ36354085-5D6DE0B4-D4BC-4B03-95C2-14E7CF5E4720Q36365301-F49713EE-6D03-4BE5-9CF8-824BA56094D4Q36365628-157E6F17-2AE7-4B30-AD64-8A7055C23139
P2860
THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION.
description
1942 nî lūn-bûn
@nan
1942年の論文
@ja
1942年論文
@yue
1942年論文
@zh-hant
1942年論文
@zh-hk
1942年論文
@zh-mo
1942年論文
@zh-tw
1942年论文
@wuu
1942年论文
@zh
1942年论文
@zh-cn
name
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@en
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@nl
type
label
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@en
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@nl
prefLabel
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@en
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@nl
P2860
P356
P1476
THE QUANTITATIVE DETERMINATION ...... ANS OF RED CELL AGGLUTINATION.
@en
P2093
P2860
P356
10.1084/JEM.75.1.49
P407
P577
1942-01-01T00:00:00Z